Sang-Yoon Park, DDS, MSD, PhD, is an Assistant Professor in the Department of Oral and Maxillofacial Surgery at Hallym University Sacred Heart Hospital, Republic of Korea. He received his DDS from Dankook University and subsequently completed both his MSD and PhD in Oral and Maxillofacial Surgery at Seoul National University, where he also completed his residency and fellowship training. Dr. Park is a board-certified specialist in Oral and Maxillofacial Surgery as well as Advanced General Dentistry, with extensive clinical experience including service as Chief of the Department of Oral and Maxillofacial Surgery at the Armed Forces Capital Hospital.
His research interests encompass temporomandibular disorders, digital therapeutics, oral cancer, dental implantology, bone regeneration, and maxillofacial reconstructive surgery. He has played a leading role in the development and clinical evaluation of digital therapeutic technologies, including the first randomized, double-blind, sham-controlled clinical trial for a mobile-based TMD intervention. In addition to digital health innovation, he maintains an active clinical research portfolio in implant science and reconstructive surgery, focusing on improving surgical outcomes and developing evidence-based treatment protocols.
Sang-Yoon Park, DDS, MSD, PhD, is an Assistant Professor in the Department of Oral and Maxillofacial Surgery at Hallym University Sacred Heart Hospital, Republic of Korea. He received his DDS from Dankook University and subsequently completed both his MSD and PhD in Oral and Maxillofacial Surgery at Seoul National University, where he also completed his residency and fellowship training. Dr. Park is a board-certified specialist in Oral and Maxillofacial Surgery as well as Advanced General Dentistry, with extensive clinical experience including service as Chief of the Department of Oral and Maxillofacial Surgery at the Armed Forces Capital Hospital.
His research interests encompass temporomandibular disorders, digital therapeutics, oral cancer, dental implantology, bone regeneration, and maxillofacial reconstructive surgery. He has played a leading role in the development and clinical evaluation of digital therapeutic technologies, including the first randomized, double-blind, sham-controlled clinical trial for a mobile-based TMD intervention. In addition to digital health innovation, he maintains an active clinical research portfolio in implant science and reconstructive surgery, focusing on improving surgical outcomes and developing evidence-based treatment protocols.